Cerba ratchets in pricing for LBO

Laboratory_testing_Fotolia_230x150
By Max Bower
07 Mar 2017

Cerba Healthcare has released price guidance of just 325bp-350bp on its €544m buyout term loan, squeezing the tightening of recent repricings even further.

The seven year loan has a 0% floor and is offered at par, well inside the last notable leveraged buyout deal for German building materials maker Xella, which came at 400bp with a 0% floor. 

The deal will provide scant respite for investors under siege from a barrage ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.